Ieq Capital LLC Sells 1,431 Shares of Teladoc Health, Inc. $TDOC

Ieq Capital LLC cut its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 11.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,833 shares of the health services provider’s stock after selling 1,431 shares during the period. Ieq Capital LLC’s holdings in Teladoc Health were worth $86,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in TDOC. Northern Trust Corp raised its position in Teladoc Health by 10.7% in the fourth quarter. Northern Trust Corp now owns 1,679,382 shares of the health services provider’s stock worth $15,266,000 after acquiring an additional 161,875 shares during the period. Mercer Global Advisors Inc. ADV raised its position in Teladoc Health by 9.6% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock worth $113,000 after acquiring an additional 1,089 shares during the period. Algert Global LLC bought a new position in Teladoc Health in the fourth quarter worth approximately $313,000. Graham Capital Management L.P. bought a new position in Teladoc Health in the fourth quarter worth approximately $183,000. Finally, Moore Capital Management LP bought a new position in Teladoc Health in the fourth quarter worth approximately $1,622,000. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $7.84 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market cap of $1.38 billion, a P/E ratio of -6.58 and a beta of 1.84. The firm’s fifty day moving average is $7.76 and its two-hundred day moving average is $7.76. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. Teladoc Health’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. As a group, analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TDOC has been the topic of several recent research reports. Evercore ISI increased their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research report on Wednesday, July 9th. Bank of America decreased their price objective on shares of Teladoc Health from $8.00 to $7.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 28th. Mizuho began coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a “neutral” rating and a $10.00 price objective on the stock. Finally, Truist Financial decreased their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Tuesday, May 27th. Six analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $9.80.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.